ATE519492T1 - Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion - Google Patents

Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion

Info

Publication number
ATE519492T1
ATE519492T1 AT04729596T AT04729596T ATE519492T1 AT E519492 T1 ATE519492 T1 AT E519492T1 AT 04729596 T AT04729596 T AT 04729596T AT 04729596 T AT04729596 T AT 04729596T AT E519492 T1 ATE519492 T1 AT E519492T1
Authority
AT
Austria
Prior art keywords
injection
notoginshen
radix
saponins
family
Prior art date
Application number
AT04729596T
Other languages
English (en)
Inventor
Weihong Xie
Xuehua Liu
Maoru Chen
Original Assignee
Li Min Pharmaceutical Factory Of Livzon Pharmceutical Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Li Min Pharmaceutical Factory Of Livzon Pharmceutical Group filed Critical Li Min Pharmaceutical Factory Of Livzon Pharmceutical Group
Application granted granted Critical
Publication of ATE519492T1 publication Critical patent/ATE519492T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04729596T 2003-05-07 2004-04-27 Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion ATE519492T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031307094A CN1329037C (zh) 2003-05-07 2003-05-07 一种三七总皂苷静脉注射液及其生产方法
PCT/CN2004/000409 WO2004098623A1 (en) 2003-05-07 2004-04-27 A notoginseng saponin intravenous injection and the method for preparing this injection

Publications (1)

Publication Number Publication Date
ATE519492T1 true ATE519492T1 (de) 2011-08-15

Family

ID=33426301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04729596T ATE519492T1 (de) 2003-05-07 2004-04-27 Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion

Country Status (6)

Country Link
US (1) US20060141070A1 (de)
EP (1) EP1637152B1 (de)
JP (1) JP4718443B2 (de)
CN (1) CN1329037C (de)
AT (1) ATE519492T1 (de)
WO (1) WO2004098623A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1771978B (zh) * 2004-11-09 2011-06-08 成都华神集团股份有限公司制药厂 一种三七三醇皂苷组合物及其制备方法和用途
CN100444845C (zh) * 2005-06-03 2008-12-24 中国医学科学院药用植物研究所 一种三七总皂苷胃肠道生物粘附制剂
CN1879637B (zh) * 2005-06-16 2010-09-15 李文军 一种治疗心脑血管病的药物
CN104784234A (zh) * 2015-04-18 2015-07-22 云南一尧科技开发有限公司 一种人参属植物口服液及其制备工艺
CN107952064B (zh) * 2016-10-14 2023-10-20 江苏豪森药业集团有限公司 含有聚乙二醇洛塞那肽的药物制剂及其制备方法
CN112710759A (zh) * 2021-03-29 2021-04-27 江西省药品检验检测研究院 脉络宁颗粒的质量检测方法
CN119607000A (zh) * 2025-01-08 2025-03-14 南京医科大学 三七皂苷r1在制备治疗化疗性周围神经病变的药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999343A (en) * 1986-09-22 1991-03-12 Yaguang Liu Production of polysaccharides and saponin of dangshen
US4968675A (en) * 1988-10-28 1990-11-06 Upjohn Non-hemolytic lazaroid parenteral formulation
JP3159543B2 (ja) * 1992-08-21 2001-04-23 アサヒ飲料株式会社 高麗人参エキスの精製法および高麗人参含有飲料
JPH06241164A (ja) * 1993-02-12 1994-08-30 Toyota Autom Loom Works Ltd ピストン式圧縮機
JPH0826226A (ja) * 1994-07-12 1996-01-30 Eisai Co Ltd バイアル瓶等の密封容器の滅菌方法とその装置
CN1067244C (zh) * 1996-02-17 2001-06-20 昆明制药股份有限公司 三七皂甙粉针剂
JPH09241164A (ja) * 1996-03-04 1997-09-16 Tsuneo Nanba 肝臓保護作用成分ギンセノサイドＲｅ／ギンセノサイドＲｇ１からなる肝臓保護薬とその製造法
CN1095363C (zh) * 1999-05-05 2002-12-04 方同华 精制血塞通注射液的生产工艺
CN1210289C (zh) * 2001-01-16 2005-07-13 长春中医学院 两头尖提取物的制备工艺和用途

Also Published As

Publication number Publication date
WO2004098623A1 (en) 2004-11-18
EP1637152B1 (de) 2011-08-10
EP1637152A8 (de) 2006-08-23
HK1085910A1 (en) 2006-09-08
US20060141070A1 (en) 2006-06-29
EP1637152A1 (de) 2006-03-22
JP2006525240A (ja) 2006-11-09
JP4718443B2 (ja) 2011-07-06
CN1513462A (zh) 2004-07-21
CN1329037C (zh) 2007-08-01
EP1637152A4 (de) 2006-03-22

Similar Documents

Publication Publication Date Title
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ATE260651T1 (de) Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
DK1218039T3 (da) Anvendelse af dialysat med höjt citratindhold
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
ATE56365T1 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung.
NO985645D0 (no) Membran-inkorporering av texapyriner
ATE519492T1 (de) Intravenöse notoginseng-saponin-injektion und verfahren zur vorbereitung dieser injektion
JorfeldtM. D et al. Lung uptake of lidocaine in man as influenced by anaesthesia, mepivacaine infusion or lung insufficiency
ATE311180T1 (de) Verfahren und pharmazeutische zusammensetzung zur verabreichung von eisen an hämodialyse- oder peritonealdialyse-patienten
ATE546136T1 (de) Kardioprotektions- und neuroprotektionsverfahren durch intravenöse verabreichung von halogenierten flüchtigen narkosemitteln
Peng et al. Comparison of three chronic dialysis models
RU2008148334A (ru) Водный экстракт листьев табака и его применение при лечении зависимости
RU2003113987A (ru) Способ лечения и профилактики заболеваний воздействием на биологически активные точки и зоны
JPH0692853A (ja) 注射剤および注射剤キット
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
RU2003135123A (ru) Способ лечения наркотических зависимостей
Graham The toxicity of sterile filtrate from parodontal pockets
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
CN1488399A (zh) 尖吻蝮蛇凝血酶用作治疗出血性疾病的药物
JP3534793B2 (ja) グリチルリチン酸直腸製剤
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
Patel et al. Toxic effects of scorpion venom (Buthus tamulus) in rabbits and guinea pigs
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE602004028328D1 (de) Verfahren zur Vorbereitung von pharmazeutischen Suspensionen zur inhalativen Verabreichung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties